At the time of writing, HeartBeam Inc [BEAT] stock is trading at $2.93, down -5.48%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BEAT shares have gain 11.41% over the last week, with a monthly amount glided 74.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
HeartBeam Inc [NASDAQ: BEAT] stock has seen the most recent analyst activity on December 11, 2025, when The Benchmark Company upgraded its rating to a Buy but kept the price target unchanged to $8 for it. Previously, H.C. Wainwright started tracking the stock with Buy rating on December 08, 2025, and set its price target to $2.50. On October 31, 2025, Roth Capital initiated with a Buy rating and assigned a price target of $4 on the stock.
For the past year, the stock price of HeartBeam Inc fluctuated between $0.54 and $4.00. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. HeartBeam Inc [NASDAQ: BEAT] shares were valued at $2.93 at the most recent close of the market. An investor can expect a potential return of 70.65% based on the average BEAT price forecast.
Analyzing the BEAT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -7.17, Equity is -5.99 and Total Capital is -51.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.75 points at the first support level, and at 2.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.14, and for the 2nd resistance point, it is at 3.36.
Ratios To Look Out For
It is important to note that HeartBeam Inc [NASDAQ:BEAT] has a current ratio of 0.86. As well, the Quick Ratio is 0.86, while the Cash Ratio is 0.75.
Transactions by insiders
Recent insider trading involved STROME MARK E, 10% Owner, that happened on Dec 17 ’25 when 0.25 million shares were sold. Director, de Urioste George completed a deal on Dec 18 ’25 to sell 33185.0 shares. Meanwhile, Director de Urioste George sold 23961.0 shares on Dec 17 ’25.
